Related Experiment Videos
Graves' IgG recognizes linear epitopes in the human thyrotropin receptor.
E V Nagy1, H B Burch, K Mahoney
1Endocrine-Metabolic Service, Walter Reed Army Medical Center, Washington, DC 20307-5001.
Biochemical and Biophysical Research Communications
|October 15, 1992
Summary
Two specific peptides from the human thyrotropin receptor extracellular domain were identified as targets for antibodies in Graves' disease patients. These findings suggest potential linear epitopes contributing to the autoimmune condition.
Area of Science:
- Endocrinology
- Immunology
- Molecular Biology
Background:
- Graves' disease is an autoimmune disorder affecting the thyroid gland.
- The thyrotropin receptor (TSHR) is the primary autoantigen in Graves' disease.
- Identifying specific TSHR epitopes targeted by autoantibodies is crucial for understanding disease pathogenesis.
Purpose of the Study:
- To synthesize peptides representing the extracellular domain of the human thyrotropin receptor.
- To test the reactivity of these peptides with sera from Graves' disease patients and healthy individuals.
- To identify specific linear epitopes on the TSHR involved in Graves' disease.
Main Methods:
- Synthesis of 29 peptides covering the full extracellular domain of the human thyrotropin receptor.
- Enzyme-linked immunosorbent assay (ELISA) to detect antibody binding.
- Comparison of antibody reactivity between Graves' disease patient sera and normal sera.
Main Results:
- Two peptides, amino acids 331-350 and the second extracellular loop, showed significant IgG binding from Graves' disease patients' sera.
- These two peptides did not bind IgG from normal individuals.
- No significant differences in binding were observed for the other 27 peptides between the groups.
Conclusions:
- Peptide 331-350 and the second extracellular loop contain important linear epitopes of the thyrotropin receptor.
- These epitopes may play a role in the autoimmune process of Graves' disease in certain patients.
- Further research into these specific epitopes could inform therapeutic strategies.